Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PMA de la FDA

System, Colorectal Neoplasia, RNA Markers and Hemoglobin detection

Número de PMA: P230001 · 2026-09-08

SolicitanteGeneoscopy, Inc.
Fecha de decisión2026-09-08
Número PMAP230001
Código de productoSBB
Clase del dispositivoClase 3
Especialidad médicaU
Comité asesorPA

Resumen del dispositivo

System, Colorectal Neoplasia, RNA Markers and Hemoglobin detection is the device name listed in this FDA 510(k) record. The listed applicant is Geneoscopy, Inc.. It received FDA 510(k) clearance on 2026-09-08. The device is classified under product code SBB. It was reviewed by the PA advisory panel.

Preguntas frecuentes

What is the System, Colorectal Neoplasia, RNA Markers and Hemoglobin detection?

System, Colorectal Neoplasia, RNA Markers and Hemoglobin detection is a medical device that received FDA 510(k) clearance on 2026-09-08. The listed applicant is Geneoscopy, Inc..

When did System, Colorectal Neoplasia, RNA Markers and Hemoglobin detection receive FDA 510(k) clearance?

The clearance date for System, Colorectal Neoplasia, RNA Markers and Hemoglobin detection can be found in the official FDA records.

Who is the listed applicant for System, Colorectal Neoplasia, RNA Markers and Hemoglobin detection?

The FDA 510(k) record lists Geneoscopy, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for System, Colorectal Neoplasia, RNA Markers and Hemoglobin detection?

The FDA product code for System, Colorectal Neoplasia, RNA Markers and Hemoglobin detection is SBB.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑